Skip to content
The African Exponent DATA
Resources

Review pending. Every figure has been checked against its cited source page in an AI-assisted source verification (6 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review

Quality Chemical

QCIL · Uganda Securities Exchange · Incorporated in Uganda · Company statements

On this page
Company details
Legal name
Quality Chemical Industries Limited
Incorporated in
Uganda
Listing
QCIL on the Uganda Securities Exchange, active · ISIN UG0000000196 (observed 2026-10-05)
Sector
Pharmaceuticals (our classification from the stated principal activity)
Activity
Manufacture and sale of pharmaceuticals, chiefly antiretroviral and anti-malarial medicines.
Financial year ends
31 March

Overview

Year ended 31 March 2026 · audited financial statements, signed / final · source

  • Revenue

    UGX 290 billion

    290,493,752 UGX thousands · p12

    +8.7% vs 2025

  • Operating profit / (loss)

    UGX 73.8 billion

    73,840,895 UGX thousands · p12

    +24.4% vs 2025

  • Profit / (loss) for the year

    UGX 56.4 billion

    56,429,162 UGX thousands · p12

    +38.8% vs 2025

  • Total assets

    UGX 239 billion

    238,793,153 UGX thousands · p13

    +4.3% vs 2025

  • Total equity

    UGX 184 billion

    183,758,960 UGX thousands · p13

    −1.5% vs 2025

  • Cash from operations

    UGX 67.5 billion

    67,549,287 UGX thousands · p15

    +122.5% vs 2025

Large amounts are rounded for reading (UGX million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.

Financial statements

Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in UGX thousands unless the row says otherwise; brackets are negative.

† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table

Column sources

  • FY to 31 Mar 2026 — audited financial statements, signed / final; reported for the year · source
  • FY to 31 Mar 2025 — audited financial statements, signed / final; comparative in the FY to 31 Mar 2026 filing · source
  • FY to 31 Mar 2024 — audited financial statements, signed / final; comparative in the FY to 31 Mar 2025 filing · source

Income statement

Income statement, UGX thousands. Columns: FY to 31 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 31 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 31 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 31 Mar 2026Audited financial statementsreported for the yearFY to 31 Mar 2025Audited financial statementscomparative in FY to 31 Mar 2026 filingFY to 31 Mar 2024Audited financial statementscomparative in FY to 31 Mar 2025 filing
Revenue 290,493,752 267,129,934 265,339,800
Cost of sales (154,718,943) (158,642,358) (175,941,930)
Gross profit 135,774,809 108,487,576 89,397,870
Other income 26,949 206,974 72,864
General and administrative expenses (66,325,845) (52,574,183) (45,769,305)
Reversal of impairment allowance1 4,364,982 3,250,396 (542,168)
Operating profit 73,840,895 59,370,763 43,159,261
Finance income 4,971,986 4,563,153 5,119,076
Finance costs (920,359) (2,257,516) (432,848)
Profit before tax 77,892,522 61,676,400 47,845,489
Taxation (21,463,360) (21,023,488) (16,085,164)
Profit for the year 56,429,162 40,652,912 31,760,325
Other comprehensive income –2 –2 –2
Total comprehensive income for the year 56,429,162 40,652,912 31,760,325
  1. Printed “-”, read as nil: subtotal_arithmetic: is.total_comprehensive_income.
Notes and alternative reported figures (1)
  1. Printed under different labels across filings: “Reversal of impairment allowance”; “Reversal of impairment allowance/(impairment allowance)”.

Balance sheet

Balance sheet, UGX thousands. Columns: FY to 31 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 31 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 31 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 31 Mar 2026Audited financial statementsreported for the yearFY to 31 Mar 2025Audited financial statementscomparative in FY to 31 Mar 2026 filingFY to 31 Mar 2024Audited financial statementscomparative in FY to 31 Mar 2025 filing
Property, plant, equipment and right-of-use assets1 48,812,755 56,173,656 61,317,371
Capital work-in-progress2 20,129,059 3,885,421 3,059,294
Intangible assets 2,440,110 1,054,870 451,018
Deferred tax asset 1,279,604 –3 Not reported in this filing4
Non-current assets 72,661,528 61,113,947 64,827,683
Inventories 91,358,503 90,525,972 86,319,714
Trade and other receivables 52,324,199 42,270,404 27,098,634
Cash in hand and at bank 22,448,923 34,989,806 53,451,182
Current assets 166,131,625 167,786,182 167,156,922
TOTAL ASSETS 238,793,153 228,900,129 231,984,605
Share capital 45,648,865 45,648,865 45,648,865
Reserves5 2,275,000 2,275,000 2,275,000
Proposed dividends6 23,372,219 21,911,455 14,972,828
Retained earnings 112,462,876 116,655,407 125,303,269
Equity 183,758,960 186,490,727 188,199,962
Deferred tax liability –7 1,136,000 155,083
Lease liabilities 92,525 175,596 168,398
Non-current liabilities 92,525 1,311,596 323,481
Lease liabilities 106,518 103,145 109,328
Trade and other payables 54,835,150 40,994,661 43,351,834
Current liabilities 54,941,668 41,097,806 43,461,162
TOTAL LIABILITIES 55,034,193 42,409,402 43,784,643
TOTAL EQUITY AND LIABILITIES 238,793,153 228,900,129 231,984,605
Current tax recoverable Not reported in this filing8 Not reported in this filing89 287,392
  1. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_assets.
  2. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
Notes and alternative reported figures (7)
  1. “Property, plant, equipment and right-of-use assets” is an issuer-specific line, not mapped to a shared definition: Quality Chemical's single balance-sheet line combining property, plant and equipment with right-of-use assets. The face of the statement prints no split, so it is not equivalent to the shared 'Property, plant and equipment' concept and is not compared with other companies.
  2. “Capital work-in-progress” is an issuer-specific line, not mapped to a shared definition: Assets under construction (note 15), presented separately from property, plant and equipment.
  3. Not reported in this filing: The FY2025 statement of financial position (p12) prints a deferred tax liability and no deferred tax asset line.
  4. “Reserves” is an issuer-specific line, not mapped to a shared definition: Valuation of land whose lease cost was waived by the Government of Uganda (note 21).
  5. “Proposed dividends” is an issuer-specific line, not mapped to a shared definition: Final dividend proposed but not yet approved, held in equity (note 22).
  6. Not reported in this filing: The FY2026 statement of financial position (p13) prints no current tax recoverable line for either year.
  7. Audited financial statements dated 2025-05-12 presents this line for this year: - (p12). Not shown in this column, which follows one filing's presentation.

Cash flow

Cash flow, UGX thousands. Columns: FY to 31 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 31 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 31 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 31 Mar 2026Audited financial statementsreported for the yearFY to 31 Mar 2025Audited financial statementscomparative in FY to 31 Mar 2026 filingFY to 31 Mar 2024Audited financial statementscomparative in FY to 31 Mar 2025 filing
Cash generated from operating activities 91,511,014 50,258,7081 82,533,215
Interest paid on bank overdraft2 (82,763) (140,404) (272,139)
Tax paid (23,878,964) (19,755,178) (15,187,591)
Net cash generated from operating activities 67,549,287 30,363,1263 67,044,617
Purchase of property, plant, and equipment (57,831) (2,754,258) (1,395,309)
Additions to capital work-in-progress4 (18,026,603) (2,923,782) (2,462,337)
Purchase of intangible assets (2,719,253) (633,852) (26,692)
Net cash used in investing activities (20,803,687) (6,311,892) (3,884,338)
Dividends paid (59,160,929) (42,362,147) (14,972,828)
Repayment of principal on lease liabilities5 (107,954) (91,380) (148,090)
Payment of interest on lease liabilities (45,856) (35,330) (28,868)
Foreign exchange differences on lease liabilities6 28,256 (23,753) Not reported in this filing7
Net cash used in financing activities (59,286,483) (42,512,610)8 (20,521,668)
Net change in cash in hand and at bank (12,540,883) (18,461,376) 42,638,611
Cash in hand and at bank at start of year 34,989,806 53,451,182 10,812,571
Cash in hand and at bank at end of year 22,448,923 34,989,806 53,451,182
Repayment of term loan Not reported in this filing9 Not reported in this filing910 (5,400,750)
Notes and alternative reported figures (10)
  1. Audited financial statements dated 2025-05-12 prints 50,234,955 (thousands, p14) for this line and year.
  2. “Interest paid on bank overdraft”: mapping to a shared definition is uncertain. Interest on the bank overdraft, mapped to interest paid on borrowings.
  3. Audited financial statements dated 2025-05-12 prints 30,304,043 (thousands, p14) for this line and year.
  4. “Additions to capital work-in-progress” is an issuer-specific line, not mapped to a shared definition: Cash spent on assets under construction (note 15).
  5. Printed under different labels across filings: “Repayment of lease liability”; “Repayment of principal on lease liabilities”.
  6. “Foreign exchange differences on lease liabilities” is an issuer-specific line, not mapped to a shared definition: Shown within financing activities (note 23(c)).
  7. Not reported in this filing: The FY2025 cash flow statement (p14) prints no foreign exchange line for lease liabilities; the line first appears in the FY2026 statements.
  8. Audited financial statements dated 2025-05-12 prints (42,453,527) (thousands, p14) for this line and year.
  9. Not reported in this filing: The FY2026 cash flow statement (p15) prints no term loan repayment line for either year.
  10. Audited financial statements dated 2025-05-12 presents this line for this year: - (p14). Not shown in this column, which follows one filing's presentation.

Per share and shares

Per share and shares. Columns: FY to 31 Mar 2026 — audited financial statements (signed / final), as reported for the year; FY to 31 Mar 2025 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2026; FY to 31 Mar 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 31 Mar 2026Audited financial statementsreported for the yearFY to 31 Mar 2025Audited financial statementscomparative in FY to 31 Mar 2026 filingFY to 31 Mar 2024Audited financial statementscomparative in FY to 31 Mar 2025 filing
Earnings / (loss) per share (per share)1 15.45 11.13 8.70
Profit / (loss) attributable to shareholders (UGX thousands)2 56,429,162 40,652,912 31,760,325
Weighted average shares (shares)3 3,651,909,200 3,651,909,200 3,651,909,200
Shares in issue at year end (shares)4 3,651,909,200 3,651,909,200 3,651,909,200
Notes and alternative reported figures (4)
  1. Earnings / (loss) per share: printed as “Basic and diluted earnings per share (UShs)”.
  2. Profit / (loss) attributable to shareholders: printed as “Profit attributable to ordinary equity holders of the Company (UShs '000)”.
  3. Weighted average shares: printed as “Weighted average number of ordinary shares in issue during the year”.
  4. Shares in issue at year end: printed as “Number of shares”.

Segments

Segment data not yet collected for this company in the pilot.

Dividends

Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.

Dividend events, the issuer's wording, and amounts as printed
Year endedEventWording as printedAmountUnitSource
31 Mar 2026 Dividend recommended, subject to shareholder approval Subject to shareholders' approval at the Annual General Meeting to be held on June 30, 2026, the Board of Directors has recommended a final dividend of UShs 6.4 per share no amount Audited financial statements, p4
31 Mar 2026 Dividend proposed per share, as printed in a statement recommended a final dividend 6.4 UGX per share Audited financial statements, p4
31 Mar 2026 Total dividend per share for the financial year total dividend 16.6 UGX per share Audited financial statements, p4
31 Mar 2026 Dividends paid (cash flow statement) Dividends paid (59,160,929) UGX thousands Audited financial statements, p15
31 Mar 2025 Dividend recommended, subject to shareholder approval Subject to shareholders' approval, the Board of Directors has recommended a final dividend of UShs 6.0 per share no amount Audited financial statements, p4
31 Mar 2025 Dividend proposed per share, as printed in a statement recommended a final dividend 6.0 UGX per share Audited financial statements, p4
31 Mar 2025 Total dividend per share for the financial year total dividend 13.5 UGX per share Audited financial statements, p4
31 Mar 2025 Total dividend per share for the financial year total dividend 13.5 UGX per share Audited financial statements, p4
31 Mar 2025 Dividends paid (cash flow statement) Dividends paid (42,362,147) UGX thousands Audited financial statements, p15
31 Mar 2024 Total dividend per share for the financial year total dividend 5.7 UGX per share Audited financial statements, p4
31 Mar 2024 Dividends paid (cash flow statement) Dividends paid (14,972,828) UGX thousands Audited financial statements, p14

Sources

Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.

  • Annual report and financial statements for the year ended March 31, 2026

    Year ended 31 March 2026 · Audited financial statements · signed / final

    Audit: Grant Thornton, unmodified opinion · signed

    Auditor's sign-off: Grant Thornton; engagement partner CPA Morris Mubangizi

    Final status: Auditor's report signed by the partner and Grant Thornton, dated 'May 28, 2026' (p11); statement of financial position signed by the chairman and the chief executive, approval date handwritten 'May 2_, 2026' with the second digit unclear (25 or 26) (p13); page images checked.

    Document date
    28 May 2026
    Auditor's report
    28 May 2026
    Board approval
    date handwritten but not legible enough to record (see notes)
    Retrieved by us
    5 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 31 Mar 2026, FY to 31 Mar 2025
    Basis
    company statements · UGX thousands (printed “UShs '000”)
    • The handwritten board approval date on p13 reads 'May 2_, 2026'; the second digit could be 5 or 6. No date is recorded.
    • Possible reclassification inferred by The African Exponent, not confirmed by the issuer: the FY2025 comparatives in these statements (p15) present payment of interest on lease liabilities (35,330) and foreign exchange differences on lease liabilities (23,753) under financing activities. 23,753 equals the difference in 'cash generated from operating activities' (50,258,708 here vs 50,234,955 in the FY2025 statements, p14), and 35,330 + 23,753 = 59,083 equals the shift between net operating cash flow (30,363,126 vs 30,304,043) and financing ((42,512,610) vs (42,453,527)). The issuer states only that comparatives were adjusted where necessary to conform to changes in presentation (note 30, p49). The discrepancy is unresolved; both reported versions are kept as printed.
    Technical details
    File
    49 pages, with a text layer
    SHA-256
    bad9f6c1095a16470c6c88f9127e4585923bc32888da6b752673ceeebe602c2c
    Entity as printed
    Quality Chemical Industries Limited (company)
    Note
    The issuer's file server returns the PDF gzip-encoded (served bytes SHA-256 a0ee9038202325b9809b3a2227dbb7b580a4ba8de00bae96620d10fcdb27a853); the archived document is the decoded PDF.
    Issuer copy
    retrieved 2026-10-05T23:40:42Z · found via https://www.qcil.com/investor-relations · Served with Content-Encoding: gzip; the decompressed bytes match the archived SHA-256.

  • Annual report and financial statements for the year ended March 31, 2025

    Year ended 31 March 2025 · Audited financial statements · signed / final

    Audit: Grant Thornton, unmodified opinion · signed

    Auditor's sign-off: Grant Thornton; engagement partner CPA Nilesh Patel

    Final status: Auditor's report signed by the partner and Grant Thornton, dated by hand '12th May 2025' (p10); statement of financial position signed by the chairman and the chief executive, approval date handwritten 'May 12, 2025' (p12); page images checked. File name says 'signed'.

    Document date
    12 May 2025
    Auditor's report
    12 May 2025
    Board approval
    12 May 2025
    Retrieved by us
    5 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 31 Mar 2024
    Basis
    company statements · UGX thousands (printed “UShs '000”)
    Technical details
    File
    42 pages, with a text layer
    SHA-256
    8797e3e2527a1dbeb68ffa6ea08a3ac336e6d80eec90e5719bce085c987a4eb3
    Entity as printed
    Quality Chemical Industries Limited (company)
    Note
    The issuer's file server returns the PDF gzip-encoded (served bytes SHA-256 98f3a68dcc43cdb1f147ea462aef558430708fb45e25b1ea7705e3c47ff9fcdf); the archived document is the decoded PDF.
    Issuer copy
    retrieved 2026-10-05T23:40:43Z · found via https://www.qcil.com/investor-relations · Served with Content-Encoding: gzip; the decompressed bytes match the archived SHA-256.

Data notes

  • Cash in hand and at bank — OCR read '53.451,182'; the page image shows '53,451,182'. OCR read a full stop for the comma. (Annual report and financial statements for the year ended March 31, 2025, p12)

Review status: every figure has been checked against its cited source page in an AI-assisted source verification (6 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.

Download

Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.

Uganda country page · Company methodology and coverage